💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks
772 results
Popular Screeners

Under USD 10/share

  • 3 Month Return43.5%

Momentum Masters

  • 3 Month Return34.8%

Technical Titans

  • 3 Month Return29%

High Beta Bulls

  • 3 Month Return19.8%

Small-Cap Growth Rockets

  • 3 Month Return16.3%

Real Estate Dividend Delights

  • 3 Month Return15.9%

Hidden Small Value Gems

  • 3 Month Return14.1%

Consistent Dividends

  • 3 Month Return11.9%

Low Volatility Leaders

  • 3 Month Return10.7%

Consumer Defensive Profit Shields

  • 3 Month Return10%
Currency in USD
Primary Listing
Overview
Insights
Valuation
Returns
Technical
Financials
Growth
Risk
Custom
Company
Exchange
Sector
Industry
Market Cap
P/E Ratio
PEG Ratio
Last Trade Price
Day Change (%)
Fair Value
Fair Value Upside
Fair Value Label
Analyst Price Target
Analyst Target Upside
Overall Health
NASDAQHealthcareBiotechnology & Medical ResearchUSD 123.02B28.3xUSD 1,139.80-0.9%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+5.8% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 120.69B-246.4x2.23USD 467-2.3%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+11% UpsideUpgrade to Pro+
OTC MarketsHealthcareBiotechnology & Medical ResearchUSD 44.97B72.6x-1.45USD 62.41-2.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+15.6% UpsideUpgrade to Pro+
NYSEHealthcareBiotechnology & Medical ResearchUSD 44B30.9x0.94USD 241.40-1.3%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+14.5% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 35.27B-475.2x-5.01USD 274.68-0.6%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+9.1% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 31.88B-154.2x-3.07USD 537.400.2%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+6% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 26.61B-47.8x0.47USD 112.02-0.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+4.3% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 25.25B-4.3x0.01USD 65.71-3.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+48.7% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 24.84B34.6x0.89USD 299.77-0.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+25% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 21.11B-39x-0.58USD 201.521.5%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+37.5% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 17.02B-53.9x-1.73USD 24.535.9%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+4.3% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 16.33B20.2x1.03USD 25.55-3.5%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+43.7% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 15.67B15.3x0.61USD 351.990.2%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+0.5% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 14.28B-25.1x0.7USD 115.49-1.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+18.9% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 13B-73.4x-1.15USD 70.28-0.8%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+9% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 12.77B-13.7x5.17USD 74.39-0.8%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+15.4% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 12.41B73.1x-1.75USD 78.12-2.8%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+7.4% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 12.10B255.4x2.4USD 126.60-0.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+59.1% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 11.95B34.6x0.41USD 118.16-1.9%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+42% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 11.24B33x1.17USD 363.88-1.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+15.9% UpsideUpgrade to Pro+
NYSEHealthcareBiotechnology & Medical ResearchUSD 10.54B24.3x-2.06USD 203.99-2.7%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+5.1% UpsideUpgrade to Pro+
NYSEHealthcareBiotechnology & Medical ResearchUSD 10B137.6x-1.81USD 44.96-1.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+12.6% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 8.99B-31.3x-0.64USD 49.05-3.5%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+73% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 8.80B-15.5x-0.61USD 153.17-0.2%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+20.4% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 7.74B-74.8x19.5USD 69.822.4%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+54% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 7.73B-5.1xUSD 53.015.8%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+-10.7% DownsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 7.61B-12.7x1.04USD 45.48-1.5%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+24.5% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 7.51B22.9x0.17USD 26.33-1.9%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+6.3% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 7.50B22.6x0.45USD 59.17-0.5%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+3.3% UpsideUpgrade to Pro+
NASDAQHealthcareBiotechnology & Medical ResearchUSD 7.47B-38.2x0.64USD 107.273.9%Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+Upgrade to Pro+-2.6% DownsideUpgrade to Pro+
  • 1
  • 2
  • ...
  • 26
  • 30 Rows
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.